[go: up one dir, main page]

WO2008136018A3 - Nouveaux congénères de 4β-amino podophyllotoxine utilisés comme agents anti-cancereux potentiels et leur procédé de préparation - Google Patents

Nouveaux congénères de 4β-amino podophyllotoxine utilisés comme agents anti-cancereux potentiels et leur procédé de préparation Download PDF

Info

Publication number
WO2008136018A3
WO2008136018A3 PCT/IN2008/000256 IN2008000256W WO2008136018A3 WO 2008136018 A3 WO2008136018 A3 WO 2008136018A3 IN 2008000256 W IN2008000256 W IN 2008000256W WO 2008136018 A3 WO2008136018 A3 WO 2008136018A3
Authority
WO
WIPO (PCT)
Prior art keywords
podophyllotoxin
preparation
anticancer agents
anilino
benzothiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000256
Other languages
English (en)
Other versions
WO2008136018A2 (fr
Inventor
Ahmed Kamal
Banala Ashwini Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority to GB0919517A priority Critical patent/GB2461667B/en
Priority to JP2010505015A priority patent/JP5355550B2/ja
Publication of WO2008136018A2 publication Critical patent/WO2008136018A2/fr
Publication of WO2008136018A3 publication Critical patent/WO2008136018A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La présente invention concerne une nouvelle classe d'analogues de 4β-[4'-(1', 3'-benzothiazole-2'-yl) anilino] podophyllotoxine représentée par la formule structurale (4) dans laquelle R = H ou CH3 ; R2 = H, halogène, CH3 et R2 = H1, halogène, OCH3. La présente invention concerne également un procédé pour la préparation de nouveaux analogues de 4β- [4'-(1', 3'-benzothiazole-2'-yl) anilino] podophyllotoxine utilisés comme agents anti-cancéreux. L'invention concerne plus particulièrement un procédé pour la préparation de dérivés 4β- [4'-(1', 3'-benzothiazoIe-2'-yl) anilino] de podophyllotoxine. Le procédé pour la synthèse de nouveaux analogues de podophyllotoxine utilisés comme agents anti-cancéreux produit les nouveaux dérivés stéréo-sélectifs de la podophyllotoxine avec de bons rendements, l'étape clé pour la synthèse de ces analogues étant la substitution nucléophile directe d'intermédiaires C-4β-iodo. L'invention concerne également la 4β-iodopodophyllotoxine, qui a été amenée à réagir avec une 4-(1,3-benzothiazole-2-yl) aniline substituée ou non substituée de façon stéréo-sélective pour produire les dérivés 4β-[4'-(1', 3'-benzothiazole-2'-yl) anilino] de la podophyllotoxine.
PCT/IN2008/000256 2007-05-03 2008-04-23 Nouveaux congénères de 4β-amino podophyllotoxine utilisés comme agents anti-cancereux potentiels et leur procédé de préparation Ceased WO2008136018A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0919517A GB2461667B (en) 2007-05-03 2008-04-23 4¼-amino podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
JP2010505015A JP5355550B2 (ja) 2007-05-03 2008-04-23 抗癌剤として新規な4β−アミノポドフィロトキシン同属体とその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN953DE2007 2007-05-03
IN953/DEL/2007 2007-05-03

Publications (2)

Publication Number Publication Date
WO2008136018A2 WO2008136018A2 (fr) 2008-11-13
WO2008136018A3 true WO2008136018A3 (fr) 2009-03-12

Family

ID=39829038

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000256 Ceased WO2008136018A2 (fr) 2007-05-03 2008-04-23 Nouveaux congénères de 4β-amino podophyllotoxine utilisés comme agents anti-cancereux potentiels et leur procédé de préparation

Country Status (4)

Country Link
US (1) US7960418B2 (fr)
JP (1) JP5355550B2 (fr)
GB (1) GB2461667B (fr)
WO (1) WO2008136018A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2638047B1 (fr) * 2010-11-11 2014-07-16 Council of Scientific and Industrial Research Dérivés de 4-beta-acrylamidopodophyllotoxin substitués en tant qu'antibiotiques antitumoraux et leur procédé de préparation
CN108285455B (zh) * 2017-08-16 2022-02-08 汤亚杰 4β-氨基取代鬼臼毒素类衍生物及其制备方法和应用
CN113402527A (zh) * 2021-06-22 2021-09-17 广东医科大学 一种鬼臼毒素结构修饰的衍生物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
WO2004033423A2 (fr) * 2002-10-11 2004-04-22 Plantaceutica Inc. Composes anticancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5541223A (en) * 1989-02-23 1996-07-30 Yale University 4β-amino podophyllotoxin analog compounds and methods
WO2004033423A2 (fr) * 2002-10-11 2004-04-22 Plantaceutica Inc. Composes anticancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIAO-KANG ZHU ET AL.: "Antitumor Agents: 194. Synthesis and Biological Evaluation of 4-beta-Mono-, -Di-, and -Trisubstituted Aniline-4'-O-demethyl-podophyllotoxin and related compounds with Improved Pharmacological Profiles", JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, 1999, pages 2441 - 2446, XP002507904 *

Also Published As

Publication number Publication date
US20080275248A1 (en) 2008-11-06
JP5355550B2 (ja) 2013-11-27
WO2008136018A2 (fr) 2008-11-13
GB2461667B (en) 2011-11-16
GB0919517D0 (en) 2009-12-23
US7960418B2 (en) 2011-06-14
JP2010526058A (ja) 2010-07-29
GB2461667A (en) 2010-01-13

Similar Documents

Publication Publication Date Title
WO2005070890A3 (fr) Intermediaires de quinoleine des inhibiteurs des recepteurs de tyrosine kinase et leur synthese
NO20082243L (no) Fremgangsmater og forbindelser for fremstiliing av CC-1065 analoger
WO2004103977A3 (fr) Procede de preparation de derives de pyrimidine
WO2011015522A3 (fr) Procédé de fabrication de composés pharmaceutiquement actifs
NO20082719L (no) Aryl-isoksazol-4-yl-oksadiazolderivater
WO2007078523A3 (fr) Composes d'oxazolidinone et leur utilisation en tant que potentialisateurs de recepteur de glutamate metabotropique
WO2007115077A3 (fr) Composés de benzimidazole bicyclique et leur utilisation comme potentialisateurs du récepteur métabotropique du glutamate
WO2010029577A3 (fr) Médicaments anticancéreux et leurs utilisations contre le mélanome malin métastatique et d'autres cancers
WO2009095933A3 (fr) Procédé perfectionné et nouveau pour la préparation de bosentan
WO2009154754A3 (fr) Synthèse de dérivés de morpholine deutérés
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
WO2009116074A3 (fr) Benzimidazoles substitués en tant que modulateur cannabinoïde
TNSN07006A1 (en) Novel heterocyclic compounds
WO2008136018A3 (fr) Nouveaux congénères de 4β-amino podophyllotoxine utilisés comme agents anti-cancereux potentiels et leur procédé de préparation
WO2007144780A3 (fr) Procédés de synthèse d'ézétimibe et composés intermédiaires pouvant être employés dans sa synthèse
WO2005000804A3 (fr) Indoles substitues et procede de preparation d'indoles substitues
WO2008059513A3 (fr) Composés appropriés comme modulateurs du hdl
WO2009021943A3 (fr) Nouveau procédé de préparation
WO2002057251A3 (fr) Procede de preparation d'intermediaires pour la fabrication de discodermolide et d'analogues de discodermolide
WO2007143014A3 (fr) Méthodes de synthèse de dérivés d'acide glutamique et de leurs intermédiaires
TW200619201A (en) Process for the preparation of pyrazoles
WO2010122580A3 (fr) Nouveaux composés inhibiteurs de rénine
WO2010012797A3 (fr) Synthèse de dérivés de 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1-carboxamidine
WO2007039117A3 (fr) Procede pour preparer des derives de sartan, et produits intermediaires pouvant etre utilises pour ce procede
WO2006136552A3 (fr) Methode de production d'intermediaires de preparation de benzimidazoles tricycliques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751452

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2010505015

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 0919517

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20080423

WWE Wipo information: entry into national phase

Ref document number: 0919517.3

Country of ref document: GB

122 Ep: pct application non-entry in european phase

Ref document number: 08751452

Country of ref document: EP

Kind code of ref document: A2